Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Scrub Recap: SpaceX has once again scrubbed the launch of the Starlink 12-21 mission. No official reason has been provided. SpaceX has confirmed they will attempt the launch no earlier than 10:20 ...

That negative investor reaction was directed at companies involved in the white-hot weight loss drug segment of the market (Eli Lilly is the pharmaceutical giant behind a popular one, Zepbound).

Scrub Recap: SpaceX has stopped fueling and has not gone live. This means SpaceX is standing down from the launch tonight. SpaceX confirmed the launch was scrubbed due to high winds in the area ...

March 10 (UPI) --NASA and SpaceX late Monday said they were standing down the launch of the SPHEREx and PUNCH spacecraft missions due to unfavorable weather at the launch site and an issue with ...

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

to scrub mentions of “diversity” and “equity.” A previous version of the page used language such as “marginalized communities,” “diverse,” “underrepresented groups,” and ...

The spacecraft, SPHEREx and PUNCH, had been expected to launch on a SpaceX rocket on Saturday. By Katrina Miller Two NASA missions will have to wait longer for a launch aboard a single rocket ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the ...